Chemistry

CHEMISTRY BY RON MAGOLDA Medical Products Department E.I. duPont de Nemours & Co. Wilmington, DeL " This publication describes the first total synthesis of the potent immunosuppressant, (-)-FK-506. T.K. Jones, 5.0. Mills, R.A. Reamer, D. Askin, et al, “Total synthesis of the immunosuppressant (-)-FK-506,” Journal of American Chemical Society Ul (3), 1157-1159, February 1, 1989. ( Alanine racemase, a pyridoxal 5’-phosphate containing enzyme, has been inhibited with a number

Written byRon Magolda
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BY RON MAGOLDA
Medical Products Department
E.I. duPont de Nemours & Co.
Wilmington, DeL

" This publication describes the first total synthesis of the potent immunosuppressant, (-)-FK-506.

T.K. Jones, 5.0. Mills, R.A. Reamer, D. Askin, et al, “Total synthesis of the immunosuppressant (-)-FK-506,” Journal of American Chemical Society Ul (3), 1157-1159, February 1, 1989.

( Alanine racemase, a pyridoxal 5’-phosphate containing enzyme, has been inhibited with a number of monohaloalanine suicide inactivators. A unique method of inactivation using trifluoroalanine that provides an alternative mechanism of inactivation.

W.S. Faraci, C.T. Walsh, “Mechanism ofinactivationofalanine racemase by b-trifluroralanine,” Biochemistry ,28 (2), 431-437, 24 January 1989.

Molecular biology cannot yet predict three-dimensional structure from a given amino acid sequence. Here, synthetic peptide fragments are linked to generate model proteins. This method will assist our understanding of protein folding and structure.

W.F. DeGrado, ZR. Wasserman, J.D. Lear, “Protein design, a minimalist approach,” Science, 243 (4891), ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies